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Abstract: Malnutrition is highly prevalent in patients with foregut tumors comprising head and neck
(HNC) and esophageal (EC) cancers, negatively impacting outcomes. International evidence-based
guidelines (EBGs) for nutrition care exist; however, translation of research evidence into practice
commonly presents considerable challenges and consequently lags. This study aimed to describe and
evaluate current international nutrition care practices compared with the best-available evidence for
patients with foregut tumors who are at high risk of malnutrition. A multi-centre prospective cohort
study enrolled 170 patients commencing treatment of curative intent for HNC (n = 119) or EC (n = 51)
in 11 cancer care settings in North America, Europe and Australia between 2016 and 2018. Adherence
criteria were derived from relevant EBG recommendations with pooled results for participating
centres reported according to the Nutrition Care Model at either system or patient levels. Adherence to
EBG recommendations was: good (≥80%) for performing baseline nutrition screening and assessment,
perioperative nutrition assessment and nutrition prescription for energy and protein targets; moderate
(≥60 to <80%) for utilizing validated screening and assessment tools and pre-radiotherapy dietitian
consultation; and poor (<60%) for initiating post-operative nutrition support within 24 h and also
dietetic consultation weekly during radiotherapy and fortnightly for 6 weeks post-radiotherapy.
In conclusion, gaps in evidence-based cancer nutrition care remain; however, this may be improved
by filling known evidence gaps through high-quality research with a concurrent evolution of EBGs to
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also encompass practical implementation guidance. These should aim to support multidisciplinary
cancer clinicians to close evidence–practice gaps throughout the patient care trajectory with clearly
defined roles and responsibilities that also address patient-reported concerns.
Keywords: head and neck cancer; esophageal cancer; malnutrition; implementation; evidence-based
practice; research translation
1. Introduction
Malnutrition is highly prevalent in patients with foregut tumors comprising head and neck (HNC)
and esophageal (EC) cancers with rates commonly reported between 30 and 80% [1–3]. Characterized
by a negative energy balance and skeletal muscle depletion, cancer-associated malnutrition is driven
by a combination of reduced food intake and deranged metabolism [4]. Its etiology in patients with
foregut tumors is complex, arising from factors related to: diagnosis (tumor location contributing to
mechanical obstruction and tumor-induced metabolic derangements, cachexia and skeletal muscle
catabolism); a prolonged, multi-modal treatment trajectory (surgery, radiotherapy and/or systemic
therapy-related extensive nutrition-impact symptoms and treatment toxicities); and patient-related
factors (age, pre-morbid nutritional status, socioeconomic circumstances and lifestyle factors such as
alcohol and tobacco use) [5–7]. Patients can present as well-nourished at diagnosis, yet, due to the
considerable disease and treatment burden, still develop the detrimental sequelae of malnutrition
irrespective of overall weight status.
The best-available evidence to guide cancer nutrition care in practice has been synthesized in
international evidence-based guidelines (EBGs) from Australia [8,9], Europe [10–14], North America [15]
and the United Kingdom [16] (Table 1), demonstrating that optimizing nutrition care delivery leads to
a positive impact on clinical, cost and patient-centred outcomes. These EBGs encompass nutrition care
recommendations for varying aspects of the patient care trajectory and offer a focused synthesis by
tumor site such as HNC [8,10,16] treatment modalities including radiotherapy and chemotherapy [9]
and surgery [10–13] or cancer nutrition care [14,15] more broadly. A range of literature synthesis
and quality appraisal methods [17–21] were employed in the development of the various EBGs;
however, key recommendations are consistent. Despite the existence of EBGs, uptake of guidelines
and translation of research evidence into practice lags up to 17 years in healthcare settings [22–26].
Underpinning quality nutrition care is the widely recognised Nutrition Care Model [27,28],
comprising three domains: (1) Appropriate Access to Care (Nutrition Screening and Nutrition
Assessment); (2) Quality Nutrition Care (Goals, Prescription, Implementation); and (3) Nutrition
Evaluation and Monitoring (Measure and Evaluate Outcomes). Figure 1 depicts typical oncological
treatment trajectories for patients with foregut tumors aligned with the Nutrition Care Model. In the
first domain, elements of evidence-based nutrition care processes encompass use of validated tools for
malnutrition screening and nutrition assessment such as the Subjective Global Assessment (SGA) [29]
or Patient-Generated Subjective Global Assessment (PG-SGA) [30] specifically designed for use in
oncology populations. Like the PG-SGA, the PG-SGA Short Form (PG-SGA SF) utilizes a patient-centric
approach through self-identification of issues that impact nutrition yet still covers the conceptual
domains of malnutrition and can therefore be used as a valid and reliable screening and monitoring
instrument [31]. Patients with highly complex care needs require early and frequent access to dietitians
with expertise in nutrition support; however, dietetic workforce resources in the cancer care setting
are often inadequate [32–34].The second domain Quality Nutrition Care focuses on nutrition care
processes around the timing and frequency of dietetic interventions, nutrition prescription, e.g., energy
and protein and implementation such as commencing nutrition support, e.g., tube feeding. In the third
domain, Measure and Evaluate Outcomes, EBGs seek to make recommendations regarding timing and
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frequency of dietetic interventions throughout the treatment trajectory and key nutrition elements and
outcomes that should be monitored, e.g., weight, intake and nutritional status.
Table 1. Evidence-based clinical practice guidelines for nutritional management of adults with cancer.
First Author, Year Origin Organisation GuidelineFocus
Appraisal
Method
Arends, 2017 [14] Europe ESPEN a Cancer GRADE b
Dort, 2017 [10] International ERAS c Society Surgery–HNC d GRADE
Thompson, 2017 [15] USA e AND f Cancer AND EAL g
Weimann, 2017 [11] Europe ESPEN Surgery SIGN h, AHCPR i
Talwar, 2016 [16] UK j BAHNO k HNC ns l
Isenring, 2013 [9] Australia DAA m RT n, CTx o NHMRC p
Findlay, 2011 [8] Australia * COSA q HNC NHMRC
Braga, 2009 [12] ** Europe ESPEN Surgery-PN r ns
Weimann, 2006 [13] ** Europe ESPEN Surgery ESPEN
a ESPEN = European Society for Clinical Nutrition and Metabolism; b GRADE = Grading of Recommendations
Assessment Development and Evaluation; c ERAS = Enhanced Recovery After Surgery; d HNC = Head and Neck
Cancer; e USA = United States of America; f AND = American Academy of Nutrition and Dietetics; g EAL =
Evidence Analysis Library; h SIGN = Scottish Intercollegiate Guidelines Network; i AHCPR = Agency for Health
Care Policy and Research; j UK = United Kingdom; k BAHNO = British Association of Head and Neck Oncologists;
l ns = not specified; m DAA = Dietitians Association of Australia; n RT = Radiotherapy; o CTx = Chemotherapy;
p NHMRC = National Health and Medical Research Council; q COSA = Clinical Oncology Society of Australia;
r PN = Parenteral Nutrition; * Endorsed by Dietitians Association of Australia, Dietitians New Zealand, British
Dietetics Association and available via Dietitians Canada Practice-Based Evidence in Nutrition online portal;
** Merged into Weimann et al., 2017 [11].
Figure 1. Overview of oncological treatment for patients with foregut tumors aligned with the Nutrition
Care Model [27,28].
Successful implementation of research evidence into clinical practice requires identification of
barriers to change and facilitators to overcome them in order for potential benefits of EBGs to be
realized [35]. A Canadian-led international qualitative study exploring the barriers and enablers to
nutrition care of patients with foregut tumors identified, firstly, a need to improve the evidence base
and, secondly, to establish a minimum data set with a view to developing standardized nutrition care
pathways with defined roles and responsibilities [36]. Recent Australian-led studies demonstrated
that the multi-strategic implementation of innovative models of care increased adherence to EBGs
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for nutritional management of patients with HNC [8] resulted in improvements in nutritional status,
quality of life [37], treatment completion, unplanned hospital admissions and associated costs of
care [38]. This study aimed to (i) describe and evaluate current international nutrition care practices
compared with the best-available evidence from published EBGs for patients with foregut tumors at
high risk of malnutrition and (ii) determine any critical points where evidence–practice gaps persist
and identify opportunities for improvement in nutrition care processes.
2. Materials and Methods
2.1. Study Design, Setting and Population
The International audit of Nutrition care in patients with FORegut tuMors (INFORM) multi-centre
prospective cohort study was undertaken at 11 cancer care settings in Canada (n = 6 from two cities),
Australia (n = 2), Italy (n = 1), the Netherlands (n = 1) and the United States of America (USA), (n = 1)
between 2016 and 2018. Participating sites were teaching hospitals required to have a registered
dietitian, clinical nutritionist or nutrition delegate available for study co-ordination. Inclusion criteria
were adult (≥18 years) patients with a diagnosis of HNC or EC commencing treatment (any modality)
of curative intent. Exclusion criteria were either absence of a treatment plan due to imminent death or
an Eastern Co-operative Oncology Group (ECOG) [39] score ≥ 4.
2.2. Outcomes
The primary outcome was adherence to EBG nutrition care recommendations throughout the
treatment trajectory for which adherence criteria based on international EBGs are presented in Table 2.
Data regarding Appropriate Access to Care (Nutrition Screening and Assessment) are reported per
usual practice at each site at the time of study enrollment and are therefore referred to here as system
level outcomes within participating centres. The remainder of the adherence criteria are reported as a
proportion of included patients and by participating site. The optimum degree of adherence to EBGs
has not been determined; however, adherence rates of 80% to set criteria has been proposed [14] and
applied in recent studies [37,38]. In this study, adherence to EBG recommendations was categorized as
good (≥80%), moderate (≥60 to <80%) and poor (<60%).
At study enrollment, each site provided cancer care setting demographics and details regarding
which nutrition care processes were already established as part of standard care. Nutrition screening
was defined as the process to identify an individual who is either malnourished or at risk of
malnutrition to determine if a detailed nutrition assessment is indicated. Each study site reported
their baseline practices regarding the validated tool or criteria used to identify patients who were
malnourished or at risk of malnutrition. The validated tools for nutrition screening used in
participating sites included the Malnutrition Screening Tool (MST) [40], Nutrition Risk Screening
2002 [41], Mini Nutrition Assessment-Short Form (MNA-SF) [42] and the Short Nutritional Assessment
Questionnaire (SNAQ) [43]. Due to the variability in the types of tools that were used, the study protocol
required participating sites to adopt the PG-SGA SF as the screening tool to facilitate longitudinal
comparisons in nutrition risk across sites. To avoid misinterpretation of adherence data related to
screening processes initiated as part of the study protocol (PG-SGA SF), each study site’s reported
baseline practices were considered to be reflective of nutrition care processes with regards to screening
and assessment. Nutrition assessment was defined as a comprehensive approach to diagnosing
nutrition problems that use a combination of medical, nutrition, medication histories, physical
examination, anthropometric measurements and laboratory data. Validated tools for comprehensive
nutritional assessment for the purpose of evaluating nutritional status and, in particular, diagnosing
the degree of malnutrition, if present, comprised both the PG-SGA [30] and SGA [29]. In this study,
the criteria for comprehensive assessment of nutritional status was not considered to have been
met where measures used in isolation, e.g., anthropometry alone were not assimilated as part of a
comprehensive evaluation of nutritional status as outlined above.
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Table 2. Adherence criteria for evidence-based guideline recommendations.
Nutrition Care Model
[28,29] Recommendation Guideline Evidence * Adherence Criteria
ACCESS TO CARE
Screening & Assessment
• Malnutrition screening should be
undertaken on all patients at diagnosis to
identify nutritional risk and then
repeated at intervals through each stage
of treatment (eg surgery,
radio/chemotherapy and post-treatment).
COSA a [8], DAA b [9]







• Malnutrition screening occurred
as part of standard care at site
prior to study enrollment.
• All patients receiving radiotherapy to the
gastrointestinal tract or head and neck
area and should be referred to the
dietitian for nutrition support.
DAA, COSA A
• Dietetic consult occurred before
week 1 of radiotherapy.
• Use a validated nutrition screening tool






• Use of validated screening tool
occurred as part of standard care
at site prior to study enrollment.
• Use a validated nutrition assessment tool





• Use of validated nutrition










• Dietetic consult occurred at least
once for every five fractions of
radiotherapy given in a single
working week period.
Prescription
• RT h: Aim for energy intakes of at least 30





• Estimated Energy Requirements
(kcal or kJ/kg/day)
• Estimated Protein Requirements
(g/kg/day)
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Table 2. Cont.
Nutrition Care Model
[28,29] Recommendation Guideline Evidence * Adherence Criteria
• Surgery: Aim for Energy intakes of at
least 30 kcal/kg/day (125 kJ/kg/day)/25–30
kcal/kg IBW i/day.











• Estimated Energy Requirements
(kcal or kJ/kg/day)
• Estimated Protein Requirements
(g/kg/day)
Implementation
• Surgery: Post-operative tube feeding







• Post-operative nutrition support
commenced within 24 h.
NUTRITION MONITORING &
EVALUATION
• Patients should be seen weekly by a
dietitian during radiotherapy. DAA, COSA A • As above
• Patients should receive minimum
fortnightly follow up by a dietitian for at
least 6 weeks post radiotherapy.
DAA, COSA A
• Dietetic consult occurred at least
once in a 14 day period
following end of radiotherapy
for three consecutive fortnights.
* Evidence rating according to appraisal method specified in individual evidence-based guideline. a COSA = Clinical Oncology Society of Australia; b DAA = Dietitians Association
of Australia; c ESPEN = European Society of Clinical Nutrition and Metabolism; d AND = Academy of Nutrition and Dietetics; e MST = Malnutrition Screening Tool; f PG-SGA =
Patient-Generated Subjective Global Assessment; g SGA = Subjective Global Assessment; h RT = Radiotherapy; i IBW = Ideal Body Weight; j ERAS = Enhanced Recovery After Surgery;
k GPP = Good Practice Point.
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Nutrition diagnosis is described as a critical step in the nutrition care model between assessment
and intervention involving the identification and labeling of the specific nutrition problems that dietetics
professionals are responsible for treating [44]. Examples of nutrition diagnoses include malnutrition
(undernutrition), unintended weight loss, increased nutrient needs, inadequate protein-energy intake
although there are many potential diagnoses that could be applied to the patient population studied
here. Secondary outcomes were the impact of adherence to EBG recommendations on treatment
completion and unplanned hospital admissions.
2.3. Data Collection
Research Electronic Data Capture (REDCap) [45] hosted at the University of Alberta, Canada, was
used to capture data collected at each participating site from electronic and paper-based electronic
medical records.
2.4. Statistical Analysis
All results are presented using descriptive statistics. Categorical variables are described as counts
and percentages while continuous variables are described as medians and quartiles. All analysis was
completed using SAS Version 9.4 (SAS Institute Inc., Cary, NC, USA).
2.5. Ethics Approval and Reporting
For Canadian locations as the international lead-site, ethics approval was obtained
(HREBA.CC-15-0238). All other participating sites obtained ethics approval from their local ethics
committee with Site-Specific Approval obtained for each of the participating sites, and patient consent
was obtained. The study is reported according to the Strengthening the Reporting of Observational
Studies in the Epidemiology (STROBE) checklist [46].
3. Results
3.1. Baseline Characteristics
Baseline patient, diagnosis and treatment characteristics are presented in Table 3. A total of 170
patients, with a diagnosis of either HNC (70.0%) or EC (30.0%) were recruited from 11 international sites.
Patients were predominantly male (78.8%), Caucasian (94.7%) with a median [Q1, Q3] age of 62 [58, 69]
years and an ECOG performance status ≤ 1 (92.8%). Tumor type was most commonly adenocarcinoma
(80.4%) for patients with oesophageal cancer and the three most common tumor sites for HNC were
oropharynx (32.8%), oral cavity (26.9%) and larynx (18.5%). Patients with HNC were more likely to
have advanced clinical stage (III/IV) than patients with EC (77.4% versus 37.3%). Most patients (74.2%)
received combined modality treatment in either adjuvant, neoadjuvant or definitive settings.
Baseline nutritional characteristics (Table 4) were similar for patients with either HNC or EC for
both median (range) body mass index (BMI) kg/m2 (26 (14–42) versus 27 (17–39)) and nutritional risk
as determined by median (range) PG-SGA SF score (7 (0–29) versus 7 (0–28)). A nutrition diagnosis
was made for 50% of patients, with missing data (33.5%) likely reflective that formalizing this is
not a universal practice amongst dietitians globally. The proportion of patients requiring nutrition
support in terms of tube feeding during treatment was high for patients receiving surgery (70.3%) and
radiotherapy (62.7%).
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Australia–Brisbane 10 (8.4%) 0 (0.0%) 10 (5.9%)
Australia–Sydney 20 (16.8%) 0 (0.0%) 20 (11.8%)
Canada-Calgary * 21 (17.6%) 10 (19.6%) 31 (18.2%)
Canada–Edmonton * 20 (16.8%) 18 (35.3%) 38 (22.4%)
Italy–Rome 19 (16.0%) 0 (0.0%) 19 (11.2%)
Netherlands-Amsterdam 20 (16.8%) 23 (45.1%) 43 (25.3%)
USA-Sacramento 9 (7.6%) 0 (0.0%) 9 (5.3%)
Age, years
median [Q1, Q3] 62 [58, 69] 65 [56, 71] 63 [57, 70]
Sex
Male 93 (78.2%) 41 (80.4%) 134 (78.8%)
Female 26 (21.8%) 10 (19.6%) 36 (21.2%)
Ethnicity
Caucasian 111 (93.3%) 50 (98.0%) 161 (94.7%)
First Nations 1 (0.8%) 0 (0.0%) 1 (0.6%)
Hispanic 2 (1.7%) 0 (0.0%) 2 (1.2%)
Asian 3 (2.5%) 1 (2.0%) 4 (2.4%)
East Indian 1 (0.8%) 0 (0.0%) 1 (0.6%)
Other 1 (0.8%) 0 (0.0%) 1 (0.6%)
Current Smoker
Yes 44 (37.0%) 13 (25.5%) 57 (33.5%)
No 75 (63.0%) 38 (74.5%) 113 (66.5%)
Alcohol use
Yes 47 (39.5%) 9 (17.6%) 56 (32.9%)
No 72 (60.5%) 42 (82.4%) 114 (67.1%)
ECOG a Performance Status
0 78 (65.5%) 32 (62.7%) 110 (64.7%)
1 32 (26.9%) 16 (31.4%) 48 (28.2%)
2 6 (5.0%) 3 (5.9%) 9 (5.3%)
3 3 (2.5%) 0 (0.0%) 3 (1.8%)
Clinical Stage
1 5 (4.2%) 4 (7.8%) 9 (5.3%)
2 8 (6.7%) 13 (25.5%) 21 (12.4%)
3 18 (15.1%) 15 (29.4%) 33 (19.4%)
4 (Any) 74 (62.2%) 4 (7.8%) 78 (45.9%)
Could not assess stage 7 (5.9%) 11 (21.6%) 16 (10.6%)
Not staged 7 (5.9%) 4 (7.8%) 11 (6.5%)
Tumor Site–Head and Neck
Primary unknown 3 (2.5%) 3 (1.8%)
Hypopharynx 10 (8.4%) 10 (5.9%)
Larynx 22 (18.5%) 22 (12.9%)
Nasopharynx 5 (4.2%) 5 (2.9%)
Oral cavity 32 (26.9%) 32 (18.8%)
Oropharynx 39 (32.8%) 39 (22.9%)
Other 3(2.5%) 3 (1.8%)
Salivary gland 5 (4.2%) 5 (2.9%)













None 5 (5.0%) 5 (9.8%) 10 (6.6%)
Chemotherapy-definitive 0 (0.0%) 2 (3.9%) 2 (1.3%)
Chemotherapy-adjuvant 0 (0.0%) 1 (2.0%) 1(0.7%)
Radiotherapy-definitive 15 (15.0%) 0 (0.0%) 15 (9.9%)
Surgery 10 (10.0%) 2 (3.9%) 12 (7.9%)
Chemoradiotherapy-definitive 54 (54.0%) 6 (11.8%) 60 (39.7%)
Surgery + adj c/neoadj d RT e 7 (7.0%) 0 (0.0%) 7 (4.6%)
Surgery + adj/neoadj CRT f 9 (9.0%) 35 (68.6%) 44 (29.1%)
* 3 participating sites each from Edmonton and Calgary. a ECOG = European Co-Operative Group; b Treatment
modality–19 patients from one site (Rome, Italy) excluded because cancer treatment was not captured; c adj =
adjuvant; d neoadj = neoadjuvant; e RT = Radiotherapy; f CRT = Chemoradiotherapy.












median [Q1, Q3] 77 [67, 91] 85 [75, 95] 81 [70, 91]
Height (cm)
median [Q1, Q3] 173 [168, 178] 176 [170, 182] 174 [169, 179]
BMI a (kg/m2)
median [Q1, Q3] 26 [23, 30] 27 [25, 31] 26 [23, 30]
Was a nutrition diagnosis made?
Yes 52 (43.7%) 33 (64.7%) 85 (50.0%)
No 27 (22.7%) 1 (2.0%) 28 (16.5%)
No data 40 (33.6%) 17 (33.3%) 57 (33.5%)
Nutritional Risk, PG-SGA b Short Form Score
(n) median [Q1, Q3] (116) 5 [1, 10] (47) 8 [4, 11] 6 [2, 11]
Location patient first introduced to cancer care setting
Inpatient 14 (11.8%) 4 (7.8%) 18 (10.6%)
Outpatient 105 (88.2%) 47 (92.2%) 152 (89.4%)
Did patient receive EN c or PN d within the last month prior to study enrollment?
Yes 16 (13.4%) 6 (11.8%) 22 (12.9%)
No 103 (86.6%) 45 (88.2%) 148 (87.1%)
a BMI = Body Mass Index; b PG-SGA = Patient-Generated Subjective Global Assessment; c EN = Enteral Nutrition;
d PN = Parenteral Nutrition.
3.2. Adherence to Evidence-Based Guideline Recommendations
Adherence to EBG recommendations is presented in Table 5. For the first domain comprising
Access to Care (Screening and Assessment), baseline nutrition care practices are as reported by each
participating site. While malnutrition screening and nutrition assessment were reported to be routinely
performed, validated tools were implemented for nutrition screening in 7/11 (64%) and for nutrition
assessment in 8/11 (73%) of centres.
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Table 5. Adherence to evidence-based guideline recommendations. Access to care (screening and
assessment) by the total number of participating sites (n = 11); quality nutrition care and nutrition





(Usual Practice in Centre at Study
Enrollment)
N









Validated nutrition assessment tool used. 8 73%
Quality Nutrition
Care
Measure—Patient Level HNC EC
Surgery (n = 26) (n = 38)
n % n %
Nutrition assessment
Pre-operative 6 23% 37 97%
Post-operative 24 92% 36 95%
Nutrition support-tube feeding
commenced
Pre-operative 1 4% 8 21%
Post-operative
within 24 h 5 19% 2 5%
within 1 to 7 days 12 46% 17 44%
Nutrition prescription, median [Q1, Q3]
Energy prescription (kcal/kg/d) 30.8 [29.6, 32.7] 26.3 [23.2, 28.1]
Protein prescription (g/kg/d) 1.3 [1.2, 1.5] 1.4 [1.2, 1.5]
Radiotherapy/Chemoradiotherapy (n = 85) (n = 41)
n # % n # %
Nutrition prescription, median [Q1, Q3]
Energy prescription (kcal/kg/d) 30.4 [26.7, 33.4] 26.7 [23.3, 28.8]






Pre-treatment (Access to Care) 54/85 64% 27/41 66%
Weekly during treatment 36/85 42% 10/41 24%
Fortnightly for 6 weeks post-treatment 11/85 13% 17/41 17%
# denotes diminishing n-value over course of RT duration.
For the second and third domains of Quality Nutrition Care and Nutrition Monitoring and
Evaluation, almost all patients undergoing treatment received nutrition assessment at some point
during their care trajectory within the study period for either HNC (116/119, 98%) or EC (50/51, 98%).
For patients undergoing surgery, nutrition assessment for patients with HNC was less frequent in
the pre-operative setting 6/26 (23%) and more common in the post-operative setting 24/26 (92%)
whereas, for patients with EC, nutrition assessment was high in both pre- and post-operative settings
(37/38, 97% and 36/38, 95%). For patients undergoing either adjuvant or definitive radiotherapy or
chemoradiotherapy, pre-treatment nutrition assessment occurred for 54/85 (64%) of patients with
HNC and 27/41 (66%) of patients with EC. The proportion of patients receiving dietitian consultation
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each week during radiotherapy (RT) ranged from 69% to 88% for patients with HNC and 41% to
74% for patients with EC. The proportion of patients that received all recommended weekly dietitian
assessments prescribed by evidence-based guidelines was 36/85 (42%) and 10/41 (24%) for patients
with HNC and EC respectively. Nutrition prescription for energy (kcal/kg) and protein (g/kg) was
similar between the surgical and radiotherapy settings in both the HNC and EC groups (Table 5).
3.3. Unplanned Admissions, Treatment Completion and Survival
Rates of unplanned admission, treatment completion and survival were similar between EC and
HNC groups. The unplanned admission rate was slightly higher for patients with EC than HNC (21/51
(41%) versus 33/119 (28%)). The overall treatment completion rate was 139/170 (82%) and was similar
between EC and HNC groups (43/51 (84%) versus 96/119 (81%). At the end of the study, the overall
proportion of patients surviving was 157/170 (92%) with no difference between EC and HNC groups
(45/51 (88%) versus 112/119 (94%).
4. Discussion
This is the first study to prospectively explore adherence to evidence-based nutrition care
processes in an international multi-centre cohort of high-nutritional-risk patients with HNC and
EC. By the adherence benchmarks described in our methods, the participating sites adhered well
(>80%) to recommendations for completing nutrition screening and assessment, perioperative nutrition
assessment and nutrition prescription for energy and protein targets. Adherence was moderate
(≥60 to <80%) for utilizing validated screening and assessment tools and pre-radiotherapy dietitian
consultation and poor (<60%) for initiating post-operative nutrition support within 24 h and also dietetic
consultation occurring weekly during radiotherapy and fortnightly for 6 weeks post-radiotherapy.
With regards to Quality Nutrition Care and Nutrition Monitoring and Evaluation, at a patient
population or system level, the proportion of patients that received dietetic assessment from week
to week ranged from 69% to 88% for patients with HNC and 41% to 74% for patients with EC.
However, patient-level data revealed the evidence-based schedule of weekly dietitian consultations
was adhered to for 42% of patients with HNC and 24% of patients with EC. This tapered further for
the recommended fortnightly for six weeks post-treatment dietitian consultations to 13% and 17%,
respectively. Our patient-level data concur with the EBGs suggesting that weight loss and nutrition
impact symptoms highlight the importance of ongoing access to nutrition care. Recommendations
regarding perioperative nutrition assessment were largely well adhered to; however, nutrition
intervention in terms of initiating post-operative nutrition support within 24 h was sub-optimal.
Reasons for low adherence with some guideline recommendations were not captured within the scope
of this study; however, given the tendency for variation in individual and institutional practices,
exploration of local barriers and facilitators to improving EBG adherence within participating centres
may be warranted.
The benefits of successful implementation of evidence-based nutrition care in line with best-practice
in high-risk tumor groups are now well-documented. Australian-led implementation studies have
demonstrated adherence to an evidence-based schedule of dietitian visits throughout treatment for HNC
and recovery leads to improved outcomes for patients including nutritional status, weight maintenance,
quality of life, treatment completion, and unplanned admissions [37,38,47]. Britton et al. [37,48] and
McCarter et al. [47,49] uniquely demonstrated that dietitian-led delivery of motivational interviewing
and cognitive behavioral therapy as part of an Eating as Treatment (EAT) intervention improved
a range of patient outcomes. From a system-level perspective, Findlay et al. [38] demonstrated a
15% relative reduction in costly unplanned hospital admissions equating to (in Australian Dollars
(AUD)) 14.65 AUD in costs avoided for every 1 AUD invested in delivering an evidence-based model
of care to patients with HNC. Further, patients who required unplanned hospital admission due to
their deteriorating condition utilized approximately twice the dietetics resources over the course of
care with a median (range) number of dietitian consultations of 15 (3–66) versus 8 (2–29), p < 0.001.
Nutrients 2020, 12, 3808 12 of 17
Inadequate dietetic resources are frequently cited as a key barrier to delivering optimum nutrition
care [33]; however, alongside medical and nursing expertise, allied health professionals are the third
pillar of the health workforce [50] and, with the required upfront organizational investment, have the
ability to deliver high value care.
Overcoming local barriers to guideline implementation, however, can be challenging and requires
a multi-strategic approach. Martin et al. [36] have highlighted the need for standardized nutrition
care pathways with clearly defined roles and responsibilities. Further, the prognostic significance
of cancer-related malnutrition and sarcopenia [51–60] in these patients warrants specific attention.
The Clinical Oncology Society of Australia (COSA) have recently articulated a Position Statement to
support the implementation of a co-ordinated, multidisciplinary pathway for screening, assessment
and treatment of these conditions [61]. A culture of review and audit is a longstanding mainstay of
quality in healthcare and the availability of EBGs to guide cancer nutrition care represent an opportunity
to establish this amongst cancer nutrition professionals as integral to overall quality in cancer care.
Our prospective audit was based on adherence criteria derived from the best-available evidence;
however, EBGs are not without limitations, particularly when evidence quality is low or evidence gaps
persist. As with all scientifically rigorous processes, the appropriateness of some EBG recommendations
should be challenged. An example highlighted in our audit is the optimum nutrition prescription
in terms of protein and energy targets. Different guidelines recommend a daily energy prescription
of either 125 kJ/kg (30 kcal/kg) [8,9] or 25–30 kcal/kg [12,14]; however, a recent study suggests
that the lower end of this range (25 kcal/kg/day) specified in some EBGs may be insufficient to
maintain positive energy balance and therefore ameliorate skeletal muscle depletion in patients
with HNC [62]. Of note, the EFFORT trial (effect of early nutritional support on frailty, functional
outcomes, and recovery of malnourished medical inpatients) implemented a systematic approach
to individualized nutritional support in high-risk inpatients which demonstrated improved clinical
outcomes, including survival [63]. However, it should also be acknowledged that merely increasing
energy and protein targets is an overly simplistic view of what is frequently an enormously challenging
aspect of self-managed care for ambulatory patients. Reasons for reduced nutritional intake are
multifactorial and require multidisciplinary management to create a path to support patients to
optimize nutrient intake. In an exploration of patient-reported barriers to following tube feeding
prescription in patients with HNC despite intensive dietetic input, Brown et al. [64] concluded that
understanding patient needs and optimizing multidisciplinary symptom management are vital to
improving adherence to nutrition care recommendations. This prompts a call to action for high-quality
research to fill known evidence gaps, and, as new findings to guide cancer nutrition care are published,
EBGs and related recommendations subsequently require ongoing updates and should be accompanied
by implementation guidance with clearly defined roles and responsibilities for multidisciplinary teams
that also address patient-reported barriers.
Study strengths include the international perspective on adherence to evidence-based practice
with a focus on tertiary referral centers that routinely manage high volumes of patients undergoing
treatment for complex, high-nutritional risk cancers. In terms of limitations, the authors acknowledge
the convenience sampling and lack of ethnic diversity in the study population may have resulted
in selection bias. Despite the increasingly cultural and linguistic diversity of Western countries
within which the study sites were located, the predominantly Caucasian study participants may be
reflective of the challenges of recruiting cohorts that are representative of the broader population
to research participation. Further, where data were reported at the system level, a truer reflection
of sustained implementation of best-practice nutrition care processes may have been captured with
whether adherence occurred at each nutrition intervention time point. Finally, the sample size was
relatively small and the 11 participating sites may not be reflective of the practice at other sites.
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5. Conclusions
From an international perspective, adherence to evidence-based guideline recommendations in line
with best-practice nutrition care of patients with HNC and EC was: good for baseline nutrition screening
and assessment processes, perioperative nutrition assessment and nutrition prescription for energy and
protein; moderate for utilizing validated screening and assessment tools and pre-radiotherapy dietitian
consultation; and poor for initiating post-operative nutrition support within 24 h, weekly dietetic
consultation during radiotherapy and fortnightly for 6 weeks post-radiotherapy. This demonstrates
there are still evidence to practice gaps in a global uptake of research evidence into practice for some
aspects of care, highlighting areas for improvement. Where evidence–practice gaps persist, a systematic,
multi-strategic approach that supports local implementation is required to better link research and
practice in order to ultimately optimize patient care and outcomes.
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